Hannah V. Giles
Birmingham, ENG B152TT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Bispecific Antibodies: Strategies Available to Optimize Their Safe Delivery in Patients with Multiple Myeloma.
Journal: Antibodies (Basel, Switzerland)
Published: November 18, 2025
NGS-based targeted sequencing guides risk-adapted and molecularly targeted therapy decisions in multiple myeloma.
Journal: British journal of haematology
Published: April 17, 2025
mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrow.
Journal: Blood advances
Published: March 10, 2025
Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trial.
Journal: British journal of haematology
Published: January 27, 2025
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies.
Journal: Antibodies (Basel, Switzerland)
Published: February 01, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
Journal: Blood cancer journal
Published: October 15, 2023
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: April 19, 2022
Last Updated: 09/26/2026